Advancing health equity through inclusive clinical research

Our Objective

Our objective is to assist health institutions with their ability to provide important contributions to clinical drug trials by better aligning drug sponsor diversity strategies with patient needs and preferences.

We seek to enhance the knowledge, influence, and involvement of health care providers who enjoy the trust of a diverse patient population. By empowering these trusted advisors, we can improve community outreach, education, and engagement in clinical trials, ensuring that diverse patient groups are adequately represented, and their health needs are effectively addressed.

Need to Address Clinical Data Gaps for Diverse Populations

Nearly 80% of new drugs approved annually lack sufficient clinical trials data to inform their safe and effective use in non-white patients despite advancements in medical research.

This data gap poses significant risks, as the routine use of unsafe or ineffective treatments in racial and ethnic can contribute to health disparities.

Need to Address Clinical Data Gaps for Diverse Populations

Nearly 80% of new drugs approved annually lack sufficient clinical trials data to inform their safe and effective use in non-white patients despite advancements in medical research.

This data gap poses significant risks, as the routine use of unsafe or ineffective treatments in racial and ethnic can contribute to health disparities.

Training & Education

Physician Investigator Training:

Providing flexible comprehensive on-demand training programs for physicians to become skilled clinical trial investigators. This includes advanced courses for Good Clinical Practices certification and CME credits.

Cultural Considerations Training:

Offering on demand specialized training for physician-investigators and their support personnel on cultural considerations in clinical trials to enhance patient engagement, participation, and retention.

Community Health Worker Training Program:

Establishing a training program for affiliated community health workers in communities served by physicians for the establishment of a support network; providing “Patient Navigators” to improve clinical trial patient engagement, featuring “TEA Talks” (Turning Education into Action) that offer practical, understandable information to patients from trusted sources.

Strategic Analysis

Physician and Patient Demographic Database:

Creating a comprehensive database of physicians and de-identified patient demographics and disease characteristics. These aggregated, anonymized graphic data can be presented to industry sponsors to facilitate efficient site selection that optimizes for recruitment of a diverse participation.

Clinical Trial Tracking and Alignment:

Implementing a system to continuously track clinical trials that align with physician expertise and patient access, enabling targeted outreach to sponsors.

Consulting Services

Revenue Generation for Non-Investigator Physicians:

Creating opportunities for non-investigator physicians to serve as clinical trial “Physician Accelerators”, generating additional revenue streams.

Grant Acquisition Opportunities:

Assisting physician-investigators with identifying and securing clinical drug trial grants.

Customized Clinical Trial Capabilities Development:

Leveraging our expertise and network to address your institution’s needs in developing and expanding clinical trial capabilities.

Our Team

James Powell, M.D.

Dr. Powell is a graduate and former faculty member (Pharmacology) at Weill Cornell Medical College. He experienced 24 years as a clinical research executive in the biopharmaceutical industry. Powell is a former member of the Secretary’s (HHS) Advisory Committee on Human Research Protections, and PhRMA’s Clinical Trials Committee.

He developed and directed The National Medical Association’s Project IMPACT that included training and education of hundreds of physicians to become clinical trial investigators and thousands of consumers and patients on the clinical trial process.

Brenda Conwell

Brenda, a seasoned clinical trials operations professional, brings 30+ years of experience to the field. Her expertise lies in strategically planning and managing Global Phase I-IV clinical trials across various therapeutic areas.

Throughout her career, she has held leadership positions in clinical operations, demonstrating proficiency in Good Clinical Practices, ethical considerations, and regulatory compliance related to human subject protection. Brenda’s background as a scientist at The Procter & Gamble Company underscores her commitment to advancing clinical research.